Recently, De Biasi et al. demonstrated IL-17-producing CD4 cells in patients with COVID-19, using polyclonal stimulation, of less than 1% and in healthy donors, of less than 0.5% [79]. The gene discussed is IL17A; the disease is COVID-19.